The National Times - Merck charged in France over changes to popular thyroid drug

Merck charged in France over changes to popular thyroid drug


Merck charged in France over changes to popular thyroid drug
Merck charged in France over changes to popular thyroid drug / Photo: © AFP/File

The French unit of German pharmaceuticals firm Merck said Wednesday that it had been charged with "aggravated deceit" for failing to inform patients of changes to a thyroid drug that could result in serious new side-effects.

Change text size:

A court had already ordered the company in 2020 to pay compensation to more than 3,300 plaintiffs in a civil case, and an appeal of that ruling was rejected by France's supreme court earlier this year.

Some 30,000 people in France reported headaches, insomnia, hair loss or dizziness from taking a new version of Levothyrox, a drug used to treat underactive thyroids or following surgery for cancer of the organ, which regulates the body's metabolism.

France is the world's biggest consumer of Levothyrox, with around 2.5 million users according to Merck, and was the first country where the new version of the drug was introduced in 2017.

The patients claim that Merck did not adequately inform them of the changes or the potential for new side effects, and a petition urging a return to the old formula has garnered some 170,000 signatures.

Merck France said its president was questioned by a judge in the southern city of Marseille on Tuesday, after which the deceit charges were filed.

"This charge in no way concerns the quality of the new Levothyrox formula," the company said, adding that it would provide "all necessary information to show there was no criminal fault of any kind".

In the civil case, judges ordered Merck to pay each of the 3,329 parties 1,000 euros ($980 at current exchange rates). The plaintiffs had asked for ten times that amount.

After its introduction in France, the new form of the drug was rolled out in around two dozen other European countries, without any problems, according to Merck.

It has said that any side effects are "normal and comparable to the old" formula.

R.Hawkins--TNT

Featured

Cardi B Wears Dramatic Feathered Headpiece at 2026 Baby2Baby Gala

Rapper Cardi B made a striking appearance at the 2026 Baby2Baby Gala in Los Angeles on November 15, donning a sculptural Tamara Ralph Spring 2026 Couture ensemble. The outfit featured a dramatic wide-brimmed headpiece adorned with white feathers and a cream-colored gown with gold detailing. B also performed at the charity event supporting children living in poverty.

Gypsy Rose Blanchard Links Leaked Calls to Ken Urker's Death in First TV Interview

Gypsy Rose Blanchard has spoken publicly for the first time regarding the death of Ken Urker, attributing his decline to the stress of leaked prison conversations and intense online harassment. In a candid interview with "60 Minutes Australia," Blanchard described Urker as the love of her life and firmly rejected insinuations that she played any role in his death.

Man Legally Changes Name to James Blunt After Six-Year Quest for Celebrity's Favorite Cheese

A British man has officially changed his legal name to James Délice de Bourgogne Blunt, fulfilling a long-standing personal wager with the singer-songwriter. The decision concludes a six-year campaign to discover the artist's preferred cheese, which was revealed as Délice de Bourgogne after Blunt’s album reached number one on the charts.

Niall Horan Fans Regret Missing Kingfishr Collaboration at Final Dublin Concert

Niall Horan concluded his four-night residency at Dublin’s 3Arena with a series of collaborations that left fans who missed the final date wishing they had been present. The singer performed alongside Irish indie folk group Kingfishr and paid an emotional tribute to late One Direction bandmate Liam Payne during the run.

Change text size: